OPTIMAL CESAREAN HEALING at South West, United States

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Introducing CeaLogic, sterile kits for the collection and application of Autologous Amniotic Fluid (AAF) at Cesarean delivery. In patented combination for extended efficacy, AAF will naturally reduce infection risk, promote healing and improve scarring

Highlights

Initial Duke study published! American Journal of Perinatology - Report
FDA registered CeaLogic kIts ready for market!
Patent protected method thru 2036!
Can be Life changing for millions of Women annually!
C-section. The most common healthcare-associated infection after surgery!

Overview

Target	$2,000,000
Minimum	$100,000
Investment Raised	$0
Previous Rounds	$600,000
Stage	MVP/Finished Product
Investor Role	Monthly Involvement

Ask a question
Got a question about this project?

OPTIMAL CESAREAN HEALING

Short Summary

Highlights

Overview

Sign up to view the full pitch

Similar Projects

Sign Out